AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 8.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $181,000 | -45.5% | 23,700 | -55.9% | 0.00% | -50.0% |
| Q1 2020 | $332,000 | -86.6% | 53,800 | -73.6% | 0.01% | -75.8% |
| Q4 2019 | $2,480,000 | +2.3% | 203,800 | -2.9% | 0.03% | -2.9% |
| Q3 2019 | $2,424,000 | +15.6% | 209,900 | 0.0% | 0.03% | +25.9% |
| Q2 2019 | $2,097,000 | -37.4% | 209,900 | -19.2% | 0.03% | -35.7% |
| Q1 2019 | $3,348,000 | +36.0% | 259,900 | +60.4% | 0.04% | +27.3% |
| Q4 2018 | $2,461,000 | -6.7% | 162,000 | +22.8% | 0.03% | +26.9% |
| Q3 2018 | $2,638,000 | +188.3% | 131,900 | +181.2% | 0.03% | +188.9% |
| Q2 2018 | $915,000 | -3.2% | 46,900 | 0.0% | 0.01% | -10.0% |
| Q1 2018 | $945,000 | +52.2% | 46,900 | 0.0% | 0.01% | +42.9% |
| Q4 2017 | $621,000 | -55.4% | 46,900 | -37.9% | 0.01% | -56.2% |
| Q3 2017 | $1,393,000 | +0.3% | 75,500 | 0.0% | 0.02% | -5.9% |
| Q2 2017 | $1,389,000 | +0.9% | 75,500 | +23.8% | 0.02% | 0.0% |
| Q1 2017 | $1,376,000 | +9.8% | 61,000 | +69.4% | 0.02% | +6.2% |
| Q4 2016 | $1,253,000 | +42.1% | 36,000 | 0.0% | 0.02% | +23.1% |
| Q3 2016 | $882,000 | +2.4% | 36,000 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $861,000 | +2.3% | 36,000 | 0.0% | 0.01% | -7.1% |
| Q1 2016 | $842,000 | -22.5% | 36,000 | 0.0% | 0.01% | -30.0% |
| Q4 2015 | $1,087,000 | – | 36,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |